PHARMACIE CRETEUR : revenue, balance sheet and financial ratios

PHARMACIE CRETEUR is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARCQ-EN-BARŒUL (59700), this company of category PME shows in 2016 a revenue of 6.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE CRETEUR (SIREN 504609405)
Indicator 2023 2022 2019 2017 2016 2015
Revenue N/C N/C N/C N/C 6 102 865 € 5 078 223 €
Net income 259 106 € 397 316 € 91 678 € 155 773 € 246 344 € 249 025 €
EBITDA N/C N/C N/C N/C 440 099 € 426 801 €
Net margin N/C N/C N/C N/C 4.0% 4.9%

Revenue and income statement

In 2023, PHARMACIE CRETEUR generates positive net income of 259 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 249 k€ -> 259 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

259 106 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 55%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

42.467%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

55.306%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.5%

Solvency indicators evolution
PHARMACIE CRETEUR

Sector positioning

Debt ratio
42.47 2023
2019
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good -11 pts over 3 years

In 2023, the debt ratio of PHARMACIE CRETEUR (42.47) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
55.31% 2023
2019
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good +11 pts over 3 years

In 2023, the financial autonomy of PHARMACIE CRETEUR (55.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 206.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

206.269

Liquidity indicators evolution
PHARMACIE CRETEUR

Sector positioning

Liquidity ratio
206.27 2023
2019
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good

In 2023, the liquidity ratio of PHARMACIE CRETEUR (206.27) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE CRETEUR

Positioning of PHARMACIE CRETEUR in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of PHARMACIE CRETEUR is estimated at 3 057 315 € (range 1 859 299€ - 4 297 898€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
1859k€ 3057k€ 4297k€
3 057 315 € Range: 1 859 299€ - 4 297 898€
NAF 5 année 2023

Valuation method used

Net Income Multiple
259 106 € × 11.8x = 3 057 315 €
Range: 1 859 300€ - 4 297 899€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE CRETEUR with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE CRETEUR

What is the revenue of PHARMACIE CRETEUR ?

The revenue of PHARMACIE CRETEUR in 2016 is 6.1 M€.

Is PHARMACIE CRETEUR profitable?

Yes, PHARMACIE CRETEUR generated a net profit of 259 k€ in 2023.

Where is the headquarters of PHARMACIE CRETEUR ?

The headquarters of PHARMACIE CRETEUR is located in MARCQ-EN-BARŒUL (59700), in the department Nord.

Where to find the tax return of PHARMACIE CRETEUR ?

The tax return of PHARMACIE CRETEUR is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE CRETEUR operate?

PHARMACIE CRETEUR operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.